Antimicrobial and Immunomodulatory Effects of Bifidobacterium Strains: A Review
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Bifidobacterium strains can provide several health benefits, such as antimicrobial and immunomodulatory effects. Some strains inhibit growth or cell adhesion of pathogenic bacteria, including multidrug-resistant bacteria, and their antibacterial activity can be intensified when combined with certain antibiotics. In addition, some strains of bifidobacteria reduce viral infectivity, leading to less epithelial damage of intestinal tissue, lowering the virus shedding titer, and controlling the release of antiviral substances. Furthermore, bifidobacteria can modulate the immune system by increasing immunoglobulins, and inducing or reducing pro- or antiinflammatory cytokines, respectively. In particular, these anti-inflammatory effects are helpful in the treatment of patients who are already suffering from infection or inflammatory diseases. This review summarizes the antimicrobial effects and mechanisms, and immunomodulatory effects of Bifidobacterium strains, suggesting the potential of bifidobacteria as an alternative or complementary treatment option.
Abstract
Bifidobacterium strains can provide several health benefits, such as antimicrobial and immunomodulatory effects. Some strains inhibit growth or cell adhesion of pathogenic bacteria, including multidrug-resistant bacteria, and their antibacterial activity can be intensified when combined with certain antibiotics. In addition, some strains of bifidobacteria reduce viral infectivity, leading to less epithelial damage of intestinal tissue, lowering the virus shedding titer, and controlling the release of antiviral substances. Furthermore, bifidobacteria can modulate the immune system by increasing immunoglobulins, and inducing or reducing pro- or antiinflammatory cytokines, respectively. In particular, these anti-inflammatory effects are helpful in the treatment of patients who are already suffering from infection or inflammatory diseases. This review summarizes the antimicrobial effects and mechanisms, and immunomodulatory effects of Bifidobacterium strains, suggesting the potential of bifidobacteria as an alternative or complementary treatment option.
참고문헌 (34)
- Cortesia C, "Acetic Acid, the active component of vinegar, is an effective tuberculocidal disinfectant", mBio, 5, pp.e00013~e00014 (2014)
- Fraise AP, "The antibacterial activity and stability of acetic acid", J. Hosp. Infect, 84, pp.329~331 (2013)
- Turroni F, "Diversity of bifidobacteria within the infant gut microbiota", PLoS One, 7, pp.e36957~ (2012)
- Mitsou EK, "Fecal microflora of Greek healthy neonates", Anaerobe, 14, pp.94~101 (2008)
- Balakrishnan RS, "The normal bacterial flora of the human intestine and its regulation", J. Clin. Gastroenterol, 41, pp.S2~S6 (2007)
- DuPont AW, "The intestinal microbiota and chronic disorders of the gut", Nat. Rev. Gastroenterol. Hepatol, 8, pp.523~531 (2011)
- Inturri R, "Growth and adhesion to HT-29 cells inhibition of Gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination", Eur. Rev. Med. Pharmacol. Sci, 20, pp.4943~4949 (2016)
- Lee DK, "Antimicrobial activity of Bifidobacterium spp. isolated from healthy adult Koreans against cariogenic microflora", Arch. Oral Biol., 56, pp.1047~1054 (2011)
- 이도경, "In Vitro Evaluation of Antibacterial Activities and Anti-inflammatory Effects of Bifidobacterium spp. Addressing Acne Vulgaris", Archives of Pharmacal Research, 35(6), pp.1065~1071 (2012), 대한약학회[DOI]
- Muñoz-Quezada S, "Isolation, identification and characterisation of three novel probiotic strains(Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036)from the faeces of exclusively breast-fed infants", Br. J. Nutr, 109, pp.S51~ (2013)
- Abdelhamid AG, "Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli", Saudi Pharm. J., 26, pp.603~607 (2018)
- 윤지희, "한국 성인에서 분리한 유산균의 VISA와 VRE에 대한 성장 억제", 약 학 회 지, 50(2), pp.78~83 (2006), 대한약학회
- Lkhagvadorj E, "Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection", Microbiol. Immunol, 54, pp.265~275 (2010)
- Yang J, "Effect of Bifidobacterium breve in combination with different antibiotics on Clostridium difficile", Front. Microbiol, 9, pp.2953~ (2018)
- Toscano M, "Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level : a preliminary study", World J. Gastroenterol, 23, pp.2696~2704 (2017)
- Parashar UD, "Global illness and deaths caused by rotavirus disease in children", Emerg. Infect. Dis, 9, pp.565~572 (2003)
- Gagnon M, "Study of the ability of bifidobacteria of human origin to prevent and treat rotavirus infection using colonic cell and mouse models", PLoS One, 11, pp.e0164512~ (2016)
- Ishizuka T, "Immunobiotic bifidobacteria strains modulate rotavirus immune response in porcine intestinal epitheliocytes via pattern recognition receptor signaling", PLoS One, 11, pp.e0152416~ (2016)
- Vlasova AN, "Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs", PLoS One, 8, pp.e76962~ (2013)
- Muñoz JA, "Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections", Appl. Environ. Microbiol., 77, pp.8775~8783 (2011)
- Holscher HD, "Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-Blind, controlled trial", J. Parenter. Enteral. Nutr., 36, pp.106S~117S (2012)
- Li-Qun Wang, "Live", Dead State Is Not the Factor Influencing Adhesion Ability of Bifidobacterium animalis KLDS2.0603, 2013, pp.51(5), 584~589[DOI]
- Natividad JM, "Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950", Appl. Environ. Microbiol, 79, pp.7745~7754 (2013)
- El Kfoury KA, "Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro", Int. J. Antimicrob. Agents, 50, pp.177~185 (2017)
- Fernandez-Duarte KP, "Bifidobacterium adolescentis(DSM 20083)and Lactobacillus casei(Lafti L26-DSL) : probiotics able to block the in vitro adherence of rotavirus in MA104 cells", Probiotics Antimicrob. Proteins, 10, pp.56~63 (2018)
- Lee A, "Consumption of dairy yogurt containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and heat-treated Lactobacillus plantarum improves immune function including natural killer cell activity", Nutrients, 9, pp.558~ (2017)
- 김경재, "Enhancement of Antigen Presentation Capability of Dendritic Cells and Activation of Macrophages by the Components of Bifidobacterium pseudocatenulatum SPM 1204", Biomolecules & Therapeutics, 13(3), pp.174~180 (2005), 한국응용약물학회
- Nakamura Y, "Upregulation of polymeric immunoglobulin receptor expression by the heat-inactivated potential probiotic Bifidobacterium bifidum OLB6378 in a mouse intestinal explant model", Scand. J. Immunol, 75, pp.176~183 (2012)
- 채정민, "Effects of Orally-Administered Bifidobacterium animalis subsp. lactis Strain BB12 on Dextran Sodium Sulfate-Induced Colitis in Mice", Journal of Microbiology and Biotechnology, 28(11), pp.1800~1805 (2018), 한국미생물·생명공학회
- Khokhlova EV, "Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants", Microbiol. Immunol, 56, pp.27~39 (2012)
- Rodes, Laetitia, "Effect of Probiotics Lactobacillus and Bifidobacterium on Gut-Derived Lipopolysaccharides and Inflammatory Cytokines: An In Vitro Study Using a Human Colonic Microbiota Model", Journal of Microbiology and Biotechnology, 23(4), pp.518~526 (2013), 한국미생물·생명공학회[DOI]
- Sheikhi A, "Probiotic yogurt culture Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5 modulate the cytokine secretion by peripheral blood mononuclear cells from patients with ulcerative colitis", Drug Res. (Stuttg), 66, pp.300~305 (2016)
- Silva AKS, "In vitro evaluation of antagonism, modulation of cytokines and extracellular matrix proteins by Bifidobacterium strains", Lett. Appl. Microbiol, 67, pp.497~505 (2018)
- Vieira AT, "Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A", Microbes Infect, 18, pp.180~189 (2016)